A Resolution designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.

2025-2026 Regular Session Introduced by Pat Gallagher and 7 co-sponsors

Designates a September 20–27, 2026 week in Pennsylvania as IPF Research and Awareness Week to boost public understanding and education, without funding or mandates.

Reported as committed

Summary of HR 529 (2025-2026) — Pennsylvania

Purpose and Intent

Designates a specific observance period in Pennsylvania: the week of September 20 through September 27, 2026.

Purpose: to designate “Idiopathic Pulmonary Fibrosis Research and Awareness Week” in order to increase awareness and understanding of idiopathic pulmonary fibrosis (IPF) and to support improved diagnosis and treatment.

Key Provisions

Official designation: The Pennsylvania General Assembly recognizes September 20–27, 2026, as IPF Research and Awareness Week.

Awareness goals: The designation aims to promote broader public understanding of IPF, encourage education about diagnostic procedures, and highlight advances in research and treatment options.

No mandates or funding: The bill does not establish new funding streams, programs, or regulatory mandates. It is primarily an acknowledgement and awareness-raising measure.

Observance activities (implied): While not explicitly mandated, the designation typically encourages schools, health organizations, and community groups to observe or acknowledge IPF awareness through events, educational activities, or proclamations.

Who Is Affected

General public in Pennsylvania, particularly individuals affected by IPF, caregivers, healthcare providers, researchers, and advocacy groups.

State agencies, healthcare institutions, and organizations may reference the designation in communications and programming related to IPF awareness.

Procedural and Timeline Considerations

Sponsorship: The bill has multiple co-sponsors, indicating bipartisan or cross-chamber interest in recognizing IPF awareness.

Co-sponsors include Rob Kauffman, Kathy Rapp, Pat Gallagher, Nikki Rivera, Tina Pickett, and Arvind Venkat.

Status and process: As a resolution, HR 529 does not create new law or funding; it serves as a formal expression of the House of Representatives. It typically requires approval by the House and possibly the Senate, followed by the governor’s signature or other customary legislative steps depending on Pennsylvania’s rules for concurrent or simple resolutions.

Timing: The designation targets a specific week in 2026; if enacted, accompanying recognition may be distributed to state agencies, health networks, and partner organizations ahead of that period.

Impact and Rationale

Public awareness: Elevates IPF as a health issue worthy of attention within Pennsylvania, potentially encouraging earlier diagnosis and better understanding among patients and clinicians.

Advocacy support: Could bolster IPF advocacy groups by providing a formal platform for education and outreach during the designated week.

Non-financial: The resolution does not allocate state funds or create new regulatory requirements; its impact is primarily informational and symbolic.

Overall, HR 529 is a commemorative resolution aimed at increasing IPF awareness in Pennsylvania by designating a specific week in September 2026 for focused education and acknowledgement, without establishing new programs or funding.